Sterling Investment Services for all your stock and options trading needs. Stock Tips

Stock and Option Trading Ideas
 
Loading
Stock & Bonds Investments Advice

Market Data and Free Tools

Markets Overview
Market Momentum
Nasdaq
Commodities
52 Week Highs
52 Week Lows
Volume Leaders
Price Advances
Price Declines
Percent Advances
Percent Declines

Symbol Lookup
Custom Quotes
Custom Portfolio


The Sterling Weekly for the week of December 27th , 2010 is now available. A copy of which can be viewed (here). In this week's edition of the Sterling Weekly, I take a look at at the results of our forecasts in the Sterling Weekly during 2010 to see how they faired. I would like to think we did fairly well. Please check out this week's edition and see how we did.



Hottest Deals of the Week


 

 
If you are looking for today's edition of the Sterling Prime Stock Newsletter, please (click here)"

Amex Biotechnology Index 'BTK'
Description: The Amex Biotechnology Index (BTK) is an equal dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. Such processes include, but are not limited to, recombinant DNA technology, molecular biology, genetic engineering, monoclonal antibody-based technology, lipid/liposome technology, and genomics. The BTK Index was established with a benchmark value of 200.00 on October 18, 1991. The BTK Index is rebalanced quarterly based on closing prices on the third Friday in January, April, July & October to ensure that each component stock continues to represent approximately equal weight in the index. Additional information on the 'BTK' can be obtained from the American Stock Exchanges product specification page (here.)
BTK Components
Company
Ticker
       
Cephalon, Inc. CEPH
Profile
chart
news
quote
Vertex Pharm. VRTX
Profile
chart
news
quote
Celgene Corp. CELG
Profile
chart
news
quote
Gilead Sciences GILD
Profile
chart
news
quote
Millennum Pharm. MLNM
Profile
chart
news
quote
Biogen Idec BIIB
Profile
chart
news
quote
Human Genome Sciences HGSI
Profile
chart
news
quote
Protein Design Labs PDLI
Profile
chart
news
quote
Genetech, Inc. DNA
Profile
chart
news
quote
Amgen, Inc. AMGN
Profile
chart
news
quote
Genzyme Corp. GENZ
Profile
chart
news
quote
Enzon Pharm. ENZN
Profile
chart
news
quote
Chiron Corp. CHIR
Profile
chart
news
quote
Medimune Inc. MEDI
Profile
chart
news
quote
Affymetrix, Inc. AFFX
Profile
chart
news
quote
Applera Corp-Celera Genomics CRA
Profile
chart
news
quote
Invitrogen Corp. IVGN
Profile
chart
news
quote
Our Analysis: posted January 9th, 2006. The 'BTK' was one of the better performing sector indices last year. I see the 'BTK' moving higher in the short term and testing 765.61 on a closing basis. If the 'BTK' closes above that level then it will have completed a long term cup pattern with our new target level being raised to 1,234.

Recent articles and Reports:
January 9th, 2006: A look at the BTK in The Sterling Weekly. Available to all (here)

A full list of all the indices tracked by Sterling Investments can be found (here)

 


Providing Investment Banking Consulting Services to Public Companies

1999 - 2005 Copyrighted, All Rights Reserved